Pfizer strikes deal with Trump administration to cut US drug prices
NeutralWorld Affairs
Pfizer has reached an agreement with the Trump administration aimed at reducing drug prices in the U.S., but consumers won't see the benefits until 2026. This deal is significant as it highlights ongoing efforts to make medications more affordable, although the delayed implementation raises questions about immediate relief for patients.
— Curated by the World Pulse Now AI Editorial System